| 10841575
|
Intergeneric poliovirus recombinants for the treatment of malignant glioma. |
Proc Natl Acad Sci U S A |
2000 |
Gromeier M;Lachmann S;Rosenfeld MR;Gutin PH;Wimmer E |
View
More |
| 12825926
|
Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81. |
J Med Chem |
2003 |
Wagner CE;Mohler ML;Kang GS;Miller DD;Geisert EE;Chang YA;Fleischer EB;Shea KJ |
View
More |
| 15279713
|
Poliovirus receptor CD155-targeted oncolysis of glioma. |
Neuro Oncol |
2004 |
Merrill MK;Bernhardt G;Sampson JH;Wikstrand CJ;Bigner DD;Gromeier M |
View
More |
| 16537583
|
Cell-type-specific repression of internal ribosome entry site activity by double-stranded RNA-binding protein 76. |
J Virol |
2006 |
Merrill MK;Dobrikova EY;Gromeier M |
View
More |
| 16809299
|
The double-stranded RNA binding protein 76:NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. |
J Virol |
2006 |
Merrill MK;Gromeier M |
View
More |
| 17079296
|
Attenuation of herpes simplex virus neurovirulence with picornavirus cis-acting genetic elements. |
J Virol |
2007 |
Campbell SA;Mulvey M;Mohr I;Gromeier M |
View
More |
| 28829151
|
Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas. |
Arch Pathol Lab Med |
2017 |
Chandramohan V;Bryant JD;Piao H;Keir ST;Lipp ES;Lefaivre M;Perkinson K;Bigner DD;Gromeier M;McLendon RE |
View
More |
| 30036712
|
Autonomic Function in Insular Glioma: An Exploratory Study. |
World Neurosurg |
2018 |
Mishra A;John AP;Shukla D;Sathyaprabha TN;Devi BI |
View
More |
| 31988324
|
Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. |
Nat Commun |
2020 |
Mosaheb MM;Dobrikova EY;Brown MC;Yang Y;Cable J;Okada H;Nair SK;Bigner DD;Ashley DM;Gromeier M |
View
More |
| 35674873
|
Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice. |
Neurotherapeutics |
2022 |
Shoaf ML;Desjardins A |
View
More |
| 37004712
|
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial. |
Lancet Child Adolesc Health |
2023 |
Thompson EM;Landi D;Brown MC;Friedman HS;McLendon R;Herndon JE 2nd;Buckley E;Bolognesi DP;Lipp E;Schroeder K;Becher OJ;Friedman AH;McKay Z;Walter A;Threatt S;Jaggers D;Desjardins A;Gromeier M;Bigner DD;Ashley DM |
View
More |
